Alivus Life Sciences Limited (BOM:543322)
India · Delayed Price · Currency is INR 1,400.50
+57.05 (4.25%)
At close: Oct 28, 2026
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 171.81 billion as of October 28, 2026. Its market cap has increased by 52.34% in one year.
Market Cap
171.81B
Enterprise Value
164.55B
Revenue
25.90B
Global Rank
n/a
Country Rank
n/a
PE Ratio
28.56
ChartMarket Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 171.81B, an increase of 87.33%. That is a compound annual growth rate of 12.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 171.81B | 52.79% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 294.05B |
| Piramal Pharma | 259.43B |
| Cohance Lifesciences | 177.35B |
| Alivus Life Sciences | 154.94B |
| Eris Lifesciences | 153.33B |
| Alembic Pharmaceuticals | 150.65B |
| NATCO Pharma | 141.53B |
| Sudeep Pharma | 111.03B |